Invesco Biotechnology & G... (PBE)
AMEX: PBE
· Real-Time Price · USD
67.97
0.29 (0.43%)
At close: Aug 19, 2025, 1:06 PM
PBE Holdings List
As of Aug 15, 2025
The Invesco Biotechnology & Genome ETF is an equity ETF with a total of 31 individual holdings.
The top holdings are Alnylam Pharmaceuticals at 7.35%, Illumina at 5.84%, Royalty Pharma plc at 5.35%, Gilead Sciences at 5.25%, and Amgen at 5.00%.
31
49.64%
Equity
219.7M
20.23
0.5000%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | ALNY | Alnylam Pharmac... | 455.98 | -0.19% | 36.13K | 7.35% |
| 2 | ILMN | Illumina, Inc. | 101.16 | +0.63% | 127.11K | 5.84% |
| 3 | RPRX | Royalty Pharma ... | 35.88 | -0.13% | 320.73K | 5.35% |
| 4 | GILD | Gilead Sciences... | 119.44 | +1.23% | 96.1K | 5.25% |
| 5 | AMGN | Amgen Inc. | 296.88 | +1.46% | 37.52K | 5.00% |
| 6 | BMRN | BioMarin Pharma... | 57.90 | +0.79% | 180.43K | 4.81% |
| 7 | UTHR | United Therapeu... | 315.95 | +0.59% | 33.3K | 4.77% |
| 8 | VRTX | Vertex Pharmace... | 395.53 | +1.45% | 23.5K | 4.21% |
| 9 | AVXL | Anavex Life Sci... | 9.38 | -2.19% | 775.98K | 3.60% |
| 10 | INCY | Incyte Corporat... | 85.42 | +0.58% | 87.52K | 3.46% |
| 11 | COLL | Collegium Pharm... | 38.30 | +0.30% | 193.99K | 3.31% |
| 12 | ARWR | Arrowhead Pharm... | 20.13 | +1.10% | 372.1K | 3.21% |
| 13 | HALO | Halozyme Therap... | 69.79 | +1.20% | 105.1K | 3.17% |
| 14 | PTGX | Protagonist The... | 56.47 | +0.45% | 123.18K | 3.11% |
| 15 | FOLD | Amicus Therapeu... | 7.42 | +0.14% | 916.5K | 3.00% |
| 16 | QGEN | Qiagen N.V. | 49.16 | +1.06% | 130.41K | 2.93% |
| 17 | ACAD | ACADIA Pharmace... | 25.14 | +0.32% | 257.74K | 2.90% |
| 18 | DVAX | Dynavax Technol... | 10.62 | -1.25% | 584.76K | 2.85% |
| 19 | VCYT | Veracyte, Inc. | 29.55 | -1.73% | 204.47K | 2.82% |
| 20 | NBIX | Neurocrine Bios... | 133.79 | +0.49% | 46.63K | 2.81% |
| 21 | RGEN | Repligen Corpor... | 125.13 | +0.85% | 46.67K | 2.72% |
| 22 | PTCT | PTC Therapeutic... | 51.45 | +3.30% | 119.49K | 2.67% |
| 23 | EXEL | Exelixis, Inc. | 37.95 | +0.50% | 132.71K | 2.35% |
| 24 | MNKD | MannKind Corpor... | 3.98 | +4.33% | 1.36M | 2.31% |
| 25 | CPRX | Catalyst Pharma... | 20.49 | +1.29% | 230.22K | 2.12% |
| 26 | EXAS | Exact Sciences ... | 45.68 | +1.31% | 101.12K | 2.09% |
| 27 | TGTX | TG Therapeutics... | 27.83 | +0.36% | 162.28K | 2.07% |
| 28 | BCRX | BioCryst Pharma... | 8.31 | -0.78% | 530.02K | 2.06% |
| 29 | CDNA | CareDx, Inc | 11.55 | -2.5% | 324.39K | 1.76% |
| 30 | AGPXX | Invesco governm... | n/a | n/a | 129.14K | 0.06% |
| 31 | -CASH.undefined | Cash/receivable... | n/a | n/a | 7.12K | < 0.01% |